These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 18772449
1. Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis. Cho AH, Kim JS, Kim SJ, Yun SC, Choi CG, Kim HR, Kwon SU, Lee DH, Kim EK, Suh DC, Kang DW. Stroke; 2008 Dec; 39(12):3424-6. PubMed ID: 18772449 [Abstract] [Full Text] [Related]
2. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ. Cerebrovasc Dis; 2013 Dec; 35(5):461-8. PubMed ID: 23735898 [Abstract] [Full Text] [Related]
3. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC, Rabinstein AA. Cerebrovasc Dis; 2012 Dec; 34(2):106-14. PubMed ID: 22868870 [Abstract] [Full Text] [Related]
4. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T, MR Stroke Study Group Investigators. Ann Neurol; 2008 Jan; 63(1):52-60. PubMed ID: 17880020 [Abstract] [Full Text] [Related]
5. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models. Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD. J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755 [Abstract] [Full Text] [Related]
6. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A, Dzialowski I, Koch R, Gahn G. J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668 [Abstract] [Full Text] [Related]
7. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models. Nisar T, Hanumanthu R, Khandelwal P. J Stroke Cerebrovasc Dis; 2019 Nov 15; 28(11):104360. PubMed ID: 31501036 [Abstract] [Full Text] [Related]
8. Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation. Kim EY, Kim SS, Na DG, Roh HG, Ryoo JW, Kim HK. J Comput Assist Tomogr; 2005 Nov 15; 29(2):264-9. PubMed ID: 15772550 [Abstract] [Full Text] [Related]
9. Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Singer OC, Berkefeld J, Lorenz MW, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T, MR Stroke Study Group Investigators. Cerebrovasc Dis; 2009 Nov 15; 27(4):368-74. PubMed ID: 19218803 [Abstract] [Full Text] [Related]
10. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1). Charidimou A, Pasi M, Fiorelli M, Shams S, von Kummer R, Pantoni L, Rost N. Stroke; 2016 Sep 15; 47(9):2364-72. PubMed ID: 27491738 [Abstract] [Full Text] [Related]
11. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke. Tütüncü S, Ziegler AM, Scheitz JF, Slowinski T, Rocco A, Endres M, Nolte CH. Stroke; 2013 Nov 15; 44(11):3217-9. PubMed ID: 24003042 [Abstract] [Full Text] [Related]
12. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology. Stroke; 2003 Aug 15; 34(8):e109-37. PubMed ID: 12869717 [Abstract] [Full Text] [Related]
14. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ. Int J Stroke; 2016 Oct 15; 11(7):783-90. PubMed ID: 27312681 [Abstract] [Full Text] [Related]
18. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD. Stroke; 2007 Feb 15; 38(2):313-8. PubMed ID: 17204683 [Abstract] [Full Text] [Related]
19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO. J Stroke Cerebrovasc Dis; 2008 Feb 15; 17(3):121-8. PubMed ID: 18436152 [Abstract] [Full Text] [Related]